Insider · CIK 0001580680

Van Wart Harold

Reports to the SEC for 2 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001580680

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-27	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-06-21	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-06-22	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-01-19	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2017-01-04	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	100,000
2016-12-30	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2016-10-27	Histogen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.2K sh	$0.25	+$4,545.25	18,181
2016-10-27	Histogen Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.2K sh	—	—	0
2016-06-23	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-01-26	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+158K sh	—	—	157,500
2015-06-11	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-05-18	CymaBay Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+7,300 sh	$3.34	+$24.4K	7,758
2015-05-18	CymaBay Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+100 sh	$3.29	+$329	7,858
2015-05-18	CymaBay Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+100 sh	$3.28	+$328	7,958
2015-01-07	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+180K sh	—	—	180,000
2014-01-06	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+141K sh	—	—	141,290
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−9,745 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+9,745 sh	—	—	9,745
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−358 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+358 sh	—	—	358
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−6,212 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+6,212 sh	—	—	6,212
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,257 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1,257 sh	—	—	1,257
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−5,535 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+5,535 sh	—	—	5,535
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,493 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1,493 sh	—	—	1,493
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−5,974 sh	—	—	0
2013-12-23	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+5,974 sh	—	—	5,974
2013-12-23	CymaBay Therapeutics, Inc.Stock Appreciation RightA Award	Director, President and CEO	AAward	+96K sh	—	—	95,997
2013-10-31	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+208K sh	—	—	207,724
2013-07-30	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jul 14
Van Wart Harold0001209191-19-039734
SEC(opens sec.gov)
Jun 254
Van Wart Harold0001209191-18-039400
SEC(opens sec.gov)
Jun 264
Conatus Pharmaceuticals Inc.0001209191-17-041829
SEC(opens sec.gov)
Jan 234
CymaBay Therapeutics, Inc.0001179110-17-001193
SEC(opens sec.gov)
Jan 64
CymaBay Therapeutics, Inc.0001179110-17-000723
SEC(opens sec.gov)
Jan 44
CymaBay Therapeutics, Inc.0001179110-17-000412
SEC(opens sec.gov)
Oct 314
Conatus Pharmaceuticals Inc.0001209191-16-147474
SEC(opens sec.gov)
Jun 244
Conatus Pharmaceuticals Inc.0001209191-16-129552
SEC(opens sec.gov)
Jan 284
CymaBay Therapeutics, Inc.0001179110-16-018112
SEC(opens sec.gov)
Jun 154
Conatus Pharmaceuticals Inc.0001209191-15-053244
SEC(opens sec.gov)
May 194
CymaBay Therapeutics, Inc.0001179110-15-008139
SEC(opens sec.gov)
Jan 84
CymaBay Therapeutics, Inc.0001179110-15-000708
SEC(opens sec.gov)
Jan 84
CymaBay Therapeutics, Inc.0001179110-14-000664
SEC(opens sec.gov)
Dec 274
CymaBay Therapeutics, Inc.0001179110-13-018558
SEC(opens sec.gov)

Companies

Address

C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE

HAYWARD, CA, 94545